336 related articles for article (PubMed ID: 27845275)
41. Highly Sensitive Near-Infrared Fluorophores for in Vivo Detection of Amyloid-β Plaques in Alzheimer's Disease.
Fu H; Cui M; Zhao L; Tu P; Zhou K; Dai J; Liu B
J Med Chem; 2015 Sep; 58(17):6972-83. PubMed ID: 26262759
[TBL] [Abstract][Full Text] [Related]
42. Pharmacokinetic analysis of the blood-brain barrier transport of 125I-amyloid beta protein 40 in wild-type and Alzheimer's disease transgenic mice (APP,PS1) and its implications for amyloid plaque formation.
Kandimalla KK; Curran GL; Holasek SS; Gilles EJ; Wengenack TM; Poduslo JF
J Pharmacol Exp Ther; 2005 Jun; 313(3):1370-8. PubMed ID: 15743932
[TBL] [Abstract][Full Text] [Related]
43. Nerve Growth Factor Gene Delivery across the Blood-Brain Barrier to Reduce Beta Amyloid Accumulation in AD Mice.
Rodrigues BDS; Kanekiyo T; Singh J
Mol Pharm; 2020 Jun; 17(6):2054-2063. PubMed ID: 32315185
[TBL] [Abstract][Full Text] [Related]
44. The potential use of H102 peptide-loaded dual-functional nanoparticles in the treatment of Alzheimer's disease.
Zhang C; Zheng X; Wan X; Shao X; Liu Q; Zhang Z; Zhang Q
J Control Release; 2014 Oct; 192():317-24. PubMed ID: 25102404
[TBL] [Abstract][Full Text] [Related]
45. Effects of hydrophobic core components in amphiphilic PDMAEMA nanoparticles on siRNA delivery.
Han S; Cheng Q; Wu Y; Zhou J; Long X; Wei T; Huang Y; Zheng S; Zhang J; Deng L; Wang X; Liang XJ; Cao H; Liang Z; Dong A
Biomaterials; 2015 Apr; 48():45-55. PubMed ID: 25701031
[TBL] [Abstract][Full Text] [Related]
46. RVG-peptide-linked trimethylated chitosan for delivery of siRNA to the brain.
Gao Y; Wang ZY; Zhang J; Zhang Y; Huo H; Wang T; Jiang T; Wang S
Biomacromolecules; 2014 Mar; 15(3):1010-8. PubMed ID: 24547943
[TBL] [Abstract][Full Text] [Related]
47. Penetratin Peptide-Functionalized Gold Nanostars: Enhanced BBB Permeability and NIR Photothermal Treatment of Alzheimer's Disease Using Ultralow Irradiance.
Yin T; Xie W; Sun J; Yang L; Liu J
ACS Appl Mater Interfaces; 2016 Aug; 8(30):19291-302. PubMed ID: 27411476
[TBL] [Abstract][Full Text] [Related]
48. Therapeutic effects of glatiramer acetate and grafted CD115⁺ monocytes in a mouse model of Alzheimer's disease.
Koronyo Y; Salumbides BC; Sheyn J; Pelissier L; Li S; Ljubimov V; Moyseyev M; Daley D; Fuchs DT; Pham M; Black KL; Rentsendorj A; Koronyo-Hamaoui M
Brain; 2015 Aug; 138(Pt 8):2399-422. PubMed ID: 26049087
[TBL] [Abstract][Full Text] [Related]
49. Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer's disease.
Glabe C
J Mol Neurosci; 2001 Oct; 17(2):137-45. PubMed ID: 11816787
[TBL] [Abstract][Full Text] [Related]
50. Clioquinol reduces zinc accumulation in neuritic plaques and inhibits the amyloidogenic pathway in AβPP/PS1 transgenic mouse brain.
Wang T; Wang CY; Shan ZY; Teng WP; Wang ZY
J Alzheimers Dis; 2012; 29(3):549-59. PubMed ID: 22269164
[TBL] [Abstract][Full Text] [Related]
51. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
[TBL] [Abstract][Full Text] [Related]
52. Tau passive immunization inhibits not only tau but also Aβ pathology.
Dai CL; Tung YC; Liu F; Gong CX; Iqbal K
Alzheimers Res Ther; 2017 Jan; 9(1):1. PubMed ID: 28073379
[TBL] [Abstract][Full Text] [Related]
53. Design and Validation of Liposomal ApoE2 Gene Delivery System to Evade Blood-Brain Barrier for Effective Treatment of Alzheimer's Disease.
Arora S; Layek B; Singh J
Mol Pharm; 2021 Feb; 18(2):714-725. PubMed ID: 32787268
[TBL] [Abstract][Full Text] [Related]
54. Polycation-detachable nanoparticles self-assembled from mPEG-PCL-g-SS-PDMAEMA for in vitro and in vivo siRNA delivery.
Lin D; Jiang Q; Cheng Q; Huang Y; Huang P; Han S; Guo S; Liang Z; Dong A
Acta Biomater; 2013 Aug; 9(8):7746-57. PubMed ID: 23624221
[TBL] [Abstract][Full Text] [Related]
55. Efficient delivery of Bcl-2-targeted siRNA using cationic polymer nanoparticles: downregulating mRNA expression level and sensitizing cancer cells to anticancer drug.
Beh CW; Seow WY; Wang Y; Zhang Y; Ong ZY; Ee PL; Yang YY
Biomacromolecules; 2009 Jan; 10(1):41-8. PubMed ID: 19072631
[TBL] [Abstract][Full Text] [Related]
56. Selective contrast enhancement of individual Alzheimer's disease amyloid plaques using a polyamine and Gd-DOTA conjugated antibody fragment against fibrillar Abeta42 for magnetic resonance molecular imaging.
Ramakrishnan M; Wengenack TM; Kandimalla KK; Curran GL; Gilles EJ; Ramirez-Alvarado M; Lin J; Garwood M; Jack CR; Poduslo JF
Pharm Res; 2008 Aug; 25(8):1861-72. PubMed ID: 18443900
[TBL] [Abstract][Full Text] [Related]
57. In vitro and in vivo characterization of several functionalized ultrasmall particles of iron oxide, vectorized against amyloid plaques and potentially able to cross the blood-brain barrier: toward earlier diagnosis of Alzheimer's disease by molecular imaging.
Ansciaux E; Burtea C; Laurent S; Crombez D; Nonclercq D; Vander Elst L; Muller RN
Contrast Media Mol Imaging; 2015; 10(3):211-24. PubMed ID: 25284012
[TBL] [Abstract][Full Text] [Related]
58. In vivo targeting of antibody fragments to the nervous system for Alzheimer's disease immunotherapy and molecular imaging of amyloid plaques.
Poduslo JF; Ramakrishnan M; Holasek SS; Ramirez-Alvarado M; Kandimalla KK; Gilles EJ; Curran GL; Wengenack TM
J Neurochem; 2007 Jul; 102(2):420-33. PubMed ID: 17596213
[TBL] [Abstract][Full Text] [Related]
59. A novel synthesis of selenium nanoparticles encapsulated PLGA nanospheres with curcumin molecules for the inhibition of amyloid β aggregation in Alzheimer's disease.
Huo X; Zhang Y; Jin X; Li Y; Zhang L
J Photochem Photobiol B; 2019 Jan; 190():98-102. PubMed ID: 30504054
[TBL] [Abstract][Full Text] [Related]
60. Development of surface-engineered PLGA nanoparticulate-delivery system of Tet1-conjugated nattokinase enzyme for inhibition of Aβ
Bhatt PC; Verma A; Al-Abbasi FA; Anwar F; Kumar V; Panda BP
Int J Nanomedicine; 2017; 12():8749-8768. PubMed ID: 29263666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
